Mild Chronic Hypoxia-Induced Hif-2 Alpha Interacts With C-Myc Through Competition With Hif-1 Alpha To Induce Hepatocellular Carcinoma Cell Proliferation

Han Mu,Ge Yu,Huikai Li,Mengmeng Wang,Yunlong Cui,Ti Zhang,Tianqiang Song,Changfu Liu

DOI: https://doi.org/10.1007/s13402-021-00625-w

IF: 7.051

2021-01-01

Cellular Oncology

Abstract:Purpose Hepatocellular carcinoma (HCC) has emerged as a leading cause of cancer-related deaths globally, in which hypoxia and activated hypoxia-inducible factors (HIFs) play important roles. The sibling rivalry between HIF-1 alpha and HIF-2 alpha in hypoxic tumor growth and progression still remains to be resolved, including in HCC. In this study, we aimed to analyze the mechanism by which HIF-1 alpha and HIF-2 alpha balance the proliferative response of HCC cells to hypoxia.Methods The expression of HIF-1 alpha, HIF-2 alpha, c-MYC, Rictor and Raptor in corresponding tumor and non-tumor tissues from twenty-six patients with HCC was analyzed. The relationships between HIF-1 alpha and HIF-2 alpha and their respective effects were evaluated further in vitro in hypoxic HCC cells using co-immunoprecipitation, chromatin immunoprecipitation, in situ proximity ligation, annexin V-FITC/PI staining apoptosis and MTT assay. In addition, short hairpin RNA (shRNA) transfections targeting HIF-1 alpha/2 alpha and Rictor and Western blotting were applied in HCC cells to study the underlying mechanism.Results We found that HIF-2 alpha expression showed a positive correlation with c-MYC expression in tumor tissues, whereas HIF-1 alpha did not. In vitro, increased HCC cell proliferation and an increased interaction between HIF-2 alpha and c-MYC were observed under mild chronic hypoxic conditions. Although mild hypoxia led to HIF-1 alpha, HIF-2 alpha and c-MYC up-regulation, we found that mTORC2-regulated HIF-2 alpha competed with HIF-1 alpha to bind to c-MYC. Moreover, we found that HIF-2 alpha knockdown decreased the expression of downstream c-MYC, suppressed hypoxic cell proliferation, and induced HCC cell apoptosis, whereas HIF-1 alpha knockdown did not. Additionally, we found that the PI3K inhibitor apitolisib counteracted the effect of HIF-2 alpha, thereby inducing HCC cell apoptosis.Conclusions Our data highlight a role of HIF-2 alpha in activating and binding c-MYC, thereby inducing HCC cell proliferation during mild chronic hypoxia. The PI3K/mTORC2/HIF-2 alpha/c-MYC axis may play a key role in this process. The PI3K inhibitor apitolisib may serve as a potential treatment option for patients suffering from HCC, especially in cases with rapidly growing tumors under mild chronic hypoxic conditions.